At the time of writing, InflaRx N.V. [IFRX] stock is trading at $1.65, up 10.00%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The IFRX shares have gain 7.84% over the last week, with a monthly amount glided 7.14%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 22, February 2024, InflaRx Appoints Jan Medina as Head of Investor Relations. In a post published today on Yahoo Finance, InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced the appointment of Jan Medina, CFA, as Vice President and Head of Investor Relations of InflaRx. Mr. Medina brings over 25 years of extensive experience across the life sciences sector and capital markets, including in the areas of investor relations, communications and equity research.
From an analyst’s perspective:
InflaRx N.V. [NASDAQ: IFRX] stock has seen the most recent analyst activity on April 05, 2023, when Guggenheim upgraded its rating to a Buy but kept the price target unchanged to $8 for it. Previously, Guggenheim downgraded its rating to Neutral on February 28, 2022. On October 28, 2021, upgrade upgraded it’s rating to Strong Buy and revised its price target to $14 on the stock. Guggenheim upgraded its rating to a Buy but stick to its price target of $16 on March 11, 2021. SVB Leerink upgraded its rating to a Outperform and raised its price target to $10 on November 06, 2020. H.C. Wainwright started tracking with a Buy rating for this stock on October 08, 2020, and assigned it a price target of $11. In a note dated June 17, 2020, BTIG Research initiated an Buy rating and provided a target price of $12 on this stock.
For the past year, the stock price of InflaRx N.V. fluctuated between $1.14 and $7.25. Currently, Wall Street analysts expect the stock to reach $6 within the next 12 months. InflaRx N.V. [NASDAQ: IFRX] shares were valued at $1.65 at the most recent close of the market. An investor can expect a potential return of 263.64% based on the average IFRX price forecast.
Analyzing the IFRX fundamentals
Gross Profit Margin for this corporation currently stands at -0.03% with Operating Profit Margin at -0.22%, Pretax Profit Margin comes in at -0.24%, and Net Profit Margin reading is -0.51%. To continue investigating profitability, this company’s Return on Assets is posted at -1.53, Equity is -2.61 and Total Capital is -22.65. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -6.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.5071 points at the first support level, and at 1.3641 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.7659, and for the 2nd resistance point, it is at 1.8817.
InflaRx N.V. [IFRX] reported earnings per share of -$0.14 for its fiscal quarter that ended on 9/29/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.26/share, meaning a difference of $0.12 and a surprise factor of 46.20%. By comparison, the stated earnings for the previous quarter ended on 6/29/2023 were -$0.15 per share as compared to estimates of -$0.33 per share, a difference of $0.18 representing a surprise of 54.50%.
Ratios To Look Out For
It is important to note that InflaRx N.V. [NASDAQ:IFRX] has a current ratio of 11.93. Further, the Quick Ratio stands at 11.78, while the Cash Ratio is 0.05.
